Salt CompositionYou Searched
Faximab 10mg Injection
Lupin Ltd.
₹9,300
WHO GMP
Certified
Long Expiry
(>8 Months)
WHO GMP
Certified
Long Expiry
(>8 Months)
Used In
Prevention of Blood clots
Customers also bought
More About Faximab
Benefits
In Prevention of Blood clots Faximab 10mg Injection prevents new blood clots from forming and prevents the existing ones from getting bigger. It works by blocking a substance in the body which is involved in blood clotting. Thus it helps your blood flow smoothly throughout the body. This can help reduce damage caused by clots in your lungs (pulmonary embolism), brain (stroke), heart (heart attack), or other blood vessels (thrombosis). It can also be used to prevent clots from forming after surgery, for example, to replace a knee or hip joint. Although it does not ?dissolve? blood clots, it can prevent them from getting bigger so your body can dissolve them over time. It can also make it less likely that parts of a clot will break off and travel to other parts of the body.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Faximab 10mg Injection is an antiplatelet medication. It works by preventing the platelets from sticking together, thereby decreasing the formation of harmful blood clots.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Faximab 10mg Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Faximab 10mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Faximab 10mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
NOT RELEVANT - Not relevant, as Faximab 10mg Injection is intended for use in hospitalised patients.
Caution Advised: Faximab 10mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Faximab 10mg Injection may be needed. Doctor consultation is advised. Use of Faximab 10mg Injection is not recommended in patients with severe kidney disease.
Caution Advised: Faximab 10mg Injection should be used with caution in patients with liver disease. Dose adjustment of Faximab 10mg Injection may be needed. Doctor consultation is advised. Use of Faximab 10mg Injection is not recommended in patients with severe liver disease.
What if I forget to take it?
If a dose of Faximab 10mg Injection is missed, it's advisable to consult your doctor.
Manufacturer Address
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India
References
Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 870-71
Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 599
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 3-4
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 354-355
Abciximab. Leiden, The Netherlands: Centocor B.V.; 1997 (14 Mar. 2019)
Drugs and Lactation Database (LactMed) (19 Feb. 2020)
Central Drugs Standard Control Organisation (CDSCO). Abciximab (14 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
